Yes, it would be fantastic if Anavex did the job. But NTRP's drug still have possibilities. I think they did not do their trial correctly (too short) and then they did not present the data correctly -- their analysis could have made it MUCH clearer that it may be effective but more time is needed to find out.

Most of the current approved Alz drugs only work for about 6 months. So a drug that maybe doesn't work as fast, but works over a much longer period of time, is still an improvement.